Sam Altman’s World now wants to link AI agents to your digital identity
OpenAI CEO Sam Altman took the technology world by surprise on Thursday with the release of Operator, his company's first AI ...
Sam Altman-backed AI biotech announces $1 billion for its lofty goal: adding 10 years to human life span
Retro Biosciences will back clinical trials for three drugs—including a potential Alzheimer’s disease treatment set to begin ...
Musk and Altman trade barbs on social media after ChatGPT co-creator's White House appearance
A war of words between Elon Musk and Sam Altman escalated on social media Thursday, as two of the most powerful men in tech ...
Elon Musk and Sam Altman cofounded OpenAI, but now they're locked in a legal battle. Here's the history of their working relationship and feud.
Elon Musk asked a judge to block OpenAI's attempt to transition from nonprofit to for-profit. It's not the first time he's ...
Cathie Wood Dumped Sam Altman's Surging Nuclear Startup. The Stock Just Received A 70% Price Target Hike.
Cathie Wood and her Ark Invest funds sold Oklo — the nuclear power startup backed by OpenAI head Sam Altman — and purchased ...
Sam Altman has ‘changed his perspective’ on Trump and wishes he hadn’t been a ‘non-playable character’ during previous term
Trump's "first buddy," Elon Musk, slammed Altman online over the $500 billion Stargate Project.
Sam Altman-backed Retro Biosciences to raise $1bn for longevity mission
Retro Biosciences is raising a $1bn round to fund the artificial intelligence-powered biotech’s mission to increase human lifespan by a decade, starting by getting its first drug into trials this year ...
Bret Baier Interviews Masa Son, Sam Altman, Larry Ellison: "We Have To Do The Big Investment For The Good Of Humanity"
OpenAI CEO Sam Altman, Oracle founder Larry Ellison and SoftBank CEO Masayoshi Son comment on President Trump’s Stargate AI ...